Indices end flat, Nifty holds 10,900; Sun Pharma tanks 9%


Continuing with their lacklustre performance for the third straight day, the equity benchmark indices settled on a flat note on Friday. While the day witnessed solid buying in bluechips such as Reliance Industries (RIL), HCL Tech, HDFC Bank and TCS, the gains in the index were capped by drubbing in counters including Sun Pharma, Bharti Airtel and L&T.

The S&P BSE Sensex ended just 13 points higher at 36,387, while NSE’s Nifty50 index held the crucial 10,900 level to close at 10,907, up 2 points. On a weekly basis, both the indices ended 1 per cent higher.

Sectorally, barring IT, all other indices ended in the red with the pharma stocks bleeding the most. The Nifty Pharma pack lost nearly 3 per cent to end the day at 8,690.

Shares of pharma bellwether Sun Pharma crashed to their six year- low of Rs 375.40 apiece in the early trade on Friday after news reports suggested fresh whistleblower documents were sent to Sebi. The stock plunged as much as 12 per cent on BSE. The company, however, in a BSE filing clarified that it was not privy to the news reported by MoneyLife. The stock, eventually, ended nearly 9 per cent lower at Rs 390.75.

Continue Reading